Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  AbbVie Inc    ABBV   US00287Y1091

ABBVIE INC (ABBV)

89
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/26/2015 06/29/2015 06/30/2015 07/01/2015 07/02/2015 Date
70.46(c) 67.18(c) 67.19(c) 68.51(c) 68.21(c) Last
9 669 509 12 057 161 11 625 858 7 694 912 6 214 631 Volume
+0.92% -4.66% +0.01% +1.96% -0.44% Change
More quotes
Financials ($)
Sales 2015 23 256 M
EBIT 2015 9 178 M
Net income 2015 6 455 M
Debt 2015 15 747 M
Yield 2015 3,08%
Sales 2016 26 654 M
EBIT 2016 10 997 M
Net income 2016 8 180 M
Debt 2016 16 897 M
Yield 2016 3,35%
PER 2015 17,55
PER 2016 13,83
EV / Sales 2015 5,35x
EV / Sales 2016 4,71x
Capitalization 108 664 M
More Financials
Company
AbbVie, Inc. is a research-based biopharmaceutical company.It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products.The company's products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, HIV, cystic fibrosis... 
Sector
Pharmaceuticals
Calendar
07/13Ex-dividend day
More about the company
Surperformance© ratings of AbbVie Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ABBVIE INC
07/03 Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
07/02 ABBVIE : to Host Second-Quarter Earnings Conference Call
07/01 ABBVIE : Data on Chronic Hepatitis C Virus Described by Researchers at AbbVie In..
06/29 ABBVIE : Expands Medical Device Facility in Sligo, Ireland With €40 Million Inve..
06/29 ABBVIE : Expands Medical Device Facility In Sligo, Ireland With €40 Million Inve..
06/26 ABBVIE : HUMIRA® (Adalimumab) Receives Positive CHMP Opinion to Treat Adult Pati..
06/22 ABBVIE : Intercept Pharmaceuticals Appoints Juan Carlos Lopez-Talavera, M.D., Ph..
06/20 ABBVIE : Galapagos raises EU4.4 million through warrant exercises
More news
Sector news : Biopharmaceuticals
07/03 Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
07/03 MALLINCKRODT : takes on FDA in fight over ADHD generic
07/03 KYOWA HAKKO KIRIN : Approval for ACOALAN in Japan
More sector news : Biopharmaceuticals
4-Traders Strategies on ABBVIE INC 
02/13A likely recovery
More Strategies
News from SeekingAlpha
12:28p Sector's Smaller Players Show The Way
07/02 WIDEPOINT CORPORATION : Does A Samsung Contract Matter With Apple's Dominance In..
07/01 THE BEST WAY TO JUDGE PAST PERFORMAN : Part 2
07/01 PREMARKET BIOTECH DIGEST : Geron's Sharp Gain, Bayer Essure AEs, Juno Moves High..
06/30 PREMARKET BIOTECH DIGEST : Celgene-Juno, AbbVie Rx Data, FDA-Gilead Lawsuit


Comments 
Advertisement
Chart ABBVIE INC
Duration : Period :
AbbVie Inc Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions